ilomastat has been researched along with Glaucoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brocchini, S; Fadda, H; Karu, K; Khaw, PT; Lockwood, A; Madaan, S; Mohamed-Ahmed, AHA | 1 |
| Levine, MA; Lukowski, ZL; Martorana, GM; Meyers, CA; Min, J; Schaefer, JL; Schultz, GS; Sherwood, MB | 1 |
| Han, JR; Han, KE; Suh, W | 1 |
| Khaw, PT; Mead, AL; Wong, TT | 2 |
| Sherwood, MB | 1 |
6 other study(ies) available for ilomastat and Glaucoma
| Article | Year |
|---|---|
LC-MS analysis to determine the biodistribution of a polymer coated ilomastat ocular implant.
Topics: Animals; Aqueous Humor; Chromatography, Liquid; Conjunctiva; Cornea; Female; Glaucoma; Hydroxamic Acids; Indoles; Polymers; Prostheses and Implants; Rabbits; Tandem Mass Spectrometry; Tissue Distribution; Vitreous Body; Wound Healing | 2018 |
Sequential Therapy with Saratin, Bevacizumab and Ilomastat to Prolong Bleb Function following Glaucoma Filtration Surgery in a Rabbit Model.
Topics: Analysis of Variance; Angiogenesis Inhibitors; Animals; Antibiotics, Antineoplastic; Bevacizumab; Blister; Combined Modality Therapy; Conjunctiva; Disease Models, Animal; Drug Therapy, Combination; Filtering Surgery; Glaucoma; Hydroxamic Acids; Indoles; Injections; Mitomycin; Postoperative Period; Rabbits; Salivary Proteins and Peptides; Time Factors; Treatment Outcome; Wound Healing | 2015 |
Safety of Using Matrix Metalloproteinase Inhibitor in Experimental Glaucoma Filtration Surgery.
Topics: Animals; Ciliary Body; Conjunctiva; Cornea; Glaucoma; Hydroxamic Acids; Indoles; Matrix Metalloproteinase Inhibitors; Microscopy, Electron, Transmission; Mitomycin; Rabbits; Trabeculectomy | 2017 |
Matrix metalloproteinase inhibition modulates postoperative scarring after experimental glaucoma filtration surgery.
Topics: Actins; Animals; Cicatrix; Conjunctiva; Enzyme Inhibitors; Female; Filtering Surgery; Glaucoma; Hydroxamic Acids; Indoles; Injections; Intraocular Pressure; Matrix Metalloproteinase Inhibitors; Postoperative Complications; Prospective Studies; Rabbits; Random Allocation; Wound Healing | 2003 |
Prolonged antiscarring effects of ilomastat and MMC after experimental glaucoma filtration surgery.
Topics: Animals; Antibiotics, Antineoplastic; Cicatrix; Conjunctiva; Disease Models, Animal; Enzyme Inhibitors; Female; Filtering Surgery; Glaucoma; Hydroxamic Acids; Indoles; Injections; Intraoperative Care; Matrix Metalloproteinase Inhibitors; Mitomycin; Postoperative Care; Prospective Studies; Rabbits; Sclera; Wound Healing | 2005 |
A sequential, multiple-treatment, targeted approach to reduce wound healing and failure of glaucoma filtration surgery in a rabbit model (an American Ophthalmological Society thesis).
Topics: Alkylating Agents; Animals; Antimetabolites; Blister; Conjunctiva; Connective Tissue; Connective Tissue Growth Factor; Disease Models, Animal; Drug Delivery Systems; Filtering Surgery; Glaucoma; Hydroxamic Acids; Immediate-Early Proteins; Indoles; Intercellular Signaling Peptides and Proteins; Intraocular Pressure; Male; Mannosephosphates; Mitomycin; Oligodeoxyribonucleotides, Antisense; Rabbits; Transforming Growth Factor beta2; Treatment Failure; Wound Healing | 2006 |